Immune regulation in atherosclerosis and other cardiometabolic diseases
Cardiovascular disease and related metabolic disorders such as diabetes, obesity and fatty liver disease are major causes of morbidity and mortality worldwide. They have many common features, such as dyslipidemia and inflammation. In our research group we focus on immune-mediated mechanisms in these conditions.
By exploring these processes through translational research, connecting basic science and the clinic, we wish to build a foundation for the development of new diagnostic and treatment targets for cardiometabolic disease.
Our research group works in the cross-section between molecular biology and biochemistry, and cardiovascular, cerebrovascular, and endocrine medicine. Our ambitious goal is to delineate novel therapeutic targets and biomarkers.
The group uses different research approaches, ranging from analyses of blood and tissue samples from patients to studies in genetically modified mice and cell culture systems, using advanced cellular and molecular biology. The group consists of people with different educational background and includes medical doctors, nutritionists, biochemists, and engineers. Such multidisciplinary competence is a great strength of our research group.
The research group is a part of the Research Institute of internal medicine at Rikshospitalet.
Tuva Børresdatter Dahl is acting group leader while Bente Halvorsen is on a sabbatical scholar in the USA during 2022/23.